Synthesis and characterization of pyruvate–isoniazid analogs and their copper complexes as potential ICL inhibitors
作者:Dipti Shingnapurkar、Prasad Dandawate、Christopher E. Anson、Annie K. Powell、Zahra Afrasiabi、Ekkehard Sinn、Shital Pandit、K. Venkateswara Swamy、Scott Franzblau、Subhash Padhye
DOI:10.1016/j.bmcl.2012.03.047
日期:2012.5
Currently used anti-tubercular drugs target actively growing () but there are no current therapies targeting persistent mycobacteria. Isocitrate lyase (ICL) is an important enzyme of the glyoxylate shunt pathway used by for sustaining intracellular infection in inflammatory macrophages under conditions of stress such as nutrient depletion and anaerobic metabolism. Since the humans do not possess this
目前使用的抗结核药物针对活跃生长的(),但目前没有针对持久性分枝杆菌的治疗方法。异柠檬酸裂解酶 (ICL) 是乙醛酸分流途径的重要酶,用于在营养耗尽和厌氧代谢等应激条件下维持炎症巨噬细胞的细胞内感染。由于人类不具备这种酶,因此它成为选择性药物设计的一个有吸引力的目标。目前的工作描述了丙酮酸-异烟肼缀合物及其铜配合物的合成和结构表征,这些配合物对 H37Rv 具有有效的抗结核活性。